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    Glaucoma, a group of multifactor ocular diseases, is the second leading cause of blindness worldwide. 
Primary open angle (POA) is the most common type of glaucoma, characterized by progressive optic 
nerve degeneration. Numerous genes and proteins have been revealed to be associated with POAG, but 
the pathologic mechanisms of the disease are still poorly understood. Proteomics, the collective study of 
proteins in an organism at a given condition, has extensively been used for the high-throughput 
identification of proteins related to POAG. A significant obstacle in proteomics studies is the data 
variability which makes it hard to interpret the results. Pathway analysis and network topological 
information can help address the challenge and provide a greater appreciation of the disease mechanism 
and progression. The purpose of this paper is to determine POAG biological and network information to 
further understand the mechanisms associated with POAG. PANTHER classification system was used, 
including classification with gene ontology, protein class and pathway. 474 gene/protein IDs were 
extracted from previous proteomic studies. Among pathways found by PANTHER classification, 
apoptosis signaling pathway was the most significant pathway (with the p-value of 5.54E-12). Other 
PANTHER categories results demonstrated that developmental processes, receptor binding, extracellular 
region and extracellular matrix proteins were the most significant biological process, molecular function, 
cellular component and protein class respectively. Pathway analysis aids to find probable mechanisms 
involved in POAG. A network analysis on proteins was also performed using STRING database and 
cytoscape software. From network analysis, candidate biomarkers for the disease were introduced. 
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INTRODUCTION 
     Glaucoma is an ocular disorder and 
neurodegenerative disease with multi-factorial 
etiology that causes damage to optic nerve [1, 
2]. It is the second most common cause of 
irreversible blindness and approximately, 60 
million people are affected by glaucoma 
worldwide [3, 4]. Glaucoma can be devided into 
two main categories: open-angle and closed-
angle. Open-angle is the most common type of 
glaucoma and in this case, eyes have normal 
structure but the intraocular fluid has no flow 
through trabecular meshwork. Closed-angle 
glaucoma is less common and drainage may be 
poor because the angle between the iris and the 
cornea is too narrow. Primary open angle 
glaucoma (POAG) is characterized by the 
presence of glaucomatous optic neuropathy 
without an identifiable secondary cause [5]. 
Prevalence of POAG in Asian countries is 
between 1 to 4 %  [6]. It is increasingly evident 
that besides intraocular pressure-generated 
stress and aging, glaucomatous 
neurodegeneration involves genetic 
predispositions and epigenetic risk factors. 
Although recent experimental studies have 
achieved many advances in understanding of 
glaucomatous neurodegeneration, key molecular 
mechanisms that can serve as treatment targets 
remain unclear [7].  
Proteomics, the collective study of proteins in 
an organism at a given condition, has 
extensively been used for the high-throughput 
identification of proteins related to POAG. For 
instance, Tezel et al., identified a number of 
serum proteins by immunoproteomic study of 
human glaucoma [8]. They identified a number 
of proteins which were diseased tissue-related 
antigens and could serve as candidate 
biomarkers of glaucoma. Duan et al. analyzed 
 




aqueous humor composition of POAG patients 
via two-dimensional gel electrophoresis and 
found seven increased proteins in aqueous 
humor of POAG patients including PGDS, 
caspase 14 precursor, transthyretin, cystain C, 
albumin precursor, and transferrin [9]. A 
primary hurdle that slows down the application 
of proteomics is the data’s high variability 
which makes it difficult to interpret proteomics 
data analysis results biologically. Another 
challenge is how to extract functional and 
biological information from a long list of 
proteins discovered from high-throughput 
proteomics [10]. 
Pathways are intricate networks of molecular 
reactions in organisms [11]. Pathway analysis 
can help organize a long list of proteins onto a 
short list of pathway knowledge maps, making 
it easy to interpret molecular mechanisms 
underlying these altered proteins or their 
expressions. Network analysis is also used to 
gain systems-level biological meanings [10]. 
Understanding of the interactomes will provide 
a much greater appreciation of what triggers 
disease onset and progression and allow a 
disease profile to be constructed which can be 
validated and modified following future 
discoveries [12]. 
The purpose of this paper is to determine POAG 
biological and network information to further 
understand the mechanisms associated with 
POAG. Network analysis can introduce some 
candidate biomarkers for the disease. 
 
MATERIALS AND METHODS 
Gene/protein expression data 
    Gene/protein IDs were extracted from 
previous studies and 474 proteins were selected 
from the papers [2, 6, 8, 9, 13-21]. The proteins 
uniprot IDs were identified from uniprot 
database (http://uniprot.org).  
Classification and pathway analysis methods 
    The 474 proteins were then functionally 
classified, using PANTHER (protein annotation 
through evolutionary relationship) classification 
system (http://pantherdb.org). PANTHER is a 
comprehensive system that combines gene 
function, ontology and pathways [22-24]. By 
running overrepresentation test, we compared 
our data list with a reference list of Homo 
sapience proteins in the PANTHER database. 
Over- and underrepresentation of ontology 
categories were determined statistically with 
Binomial distribution test. 
Protein-protein interaction analysis methods  
    Network analysis on proteins was performed 
using STRING (Search Tool for the Retrieval of 
Interacting Genes/Proteins) server (http://string-
db.org)  [25] and Cytoscape software  [26]. 
STRING is a database of known and predicted 
protein interactions. The interactions include 
direct (physical) and indirect (functional) 
associations. A network from the gene list was 
constructed by STRING. Disconnected nodes 
were eliminated. This network was then 
analyzed using Cytoscape 3.0.2 software. 
Cytocluster application was used to cluster the 
network into subnetworks. The clustering was 
done using HC-PIN nonoverlapping algorithm 




     Pathway analysis was performed using 
PANTHER classification system. 
Overrepresentation test was run which 
compares our data list to a reference list. Here, 
we used the default Homo sapiens reference list 
of the PANTHER database. Overrepresentation 
means we observe more genes than expected 
based on the reference list. Conversely, 
underrepresentation refers to less observed 
genes than expected from the reference list. 
Binomial distribution test is used for the 
comparison. 
The gene ontology including biological process, 
molecular function and cellular component was 
performed on the list. Bonferroni correction is 
used on the results. Table 1 shows the biological 
processes related to POAG. According to the 
table, developmental process, response to 
stimulus and cellular process were the most 
significant with least p-values. Table2 shows 
the molecular functions. Receptor binding, 
extracellular matrix structural constituent and 
protein binding are the most important 
molecular functions related to POAG. Table 3 
shows the cellular components found from the 
protein list. Extracellular region and 
extracellular matrix have the least p-values in 
this category. 
Protein classes were also identified by 
PANTHER (table 4). Extracellular matrix 
proteins, signaling molecules and extracellular 
matrix structural proteins were the most 
important ones. Pathway analysis was done both 
by overrepresentation test and functional 
classification.
 





Table 1. Top 10 biological processes related to POAG. 
GO Biological Process Homo sapiens (REF) # # Expected +/_ P-value 
Unclassified 9422 68 143.46 - 4.00E-16 
developmental process 2846 103 43.33 + 2.46E-15 
response to stimulus 1671 73 25.44 + 4.57E-14 
cellular process 5952 156 90.63 + 2.94E-12 
immune system process 1733 70 26.39 + 9.96E-12 
cell death 697 39 10.61 + 8.26E-10 
apoptotic process 697 39 10.61 + 8.26E-10 
Death 699 39 10.64 + 8.99E-10 
macrophage activation 289 21 4.40 + 1.14E-06 
cell communication 3221 89 49.04 + 1.73E-06 
cell adhesion 890 38 13.55 + 2.68E-06 
+/- shows over- and under representations. Second and third column contains the number of genes in reference list and 
our list respectively. P-value threshold is considered 0.05 
 
Table 2. Top 10 molecular functions related to POAG 
Molecular Function Homo sapiens (REF) # # Expected +/_       P-value 
Unclassified 10605 93 161.48 _ 2.27E-12 
receptor binding 1017 40 15.49 + 8.83E-06 
extracellular matrix structural constituent 91 11 1.39 + 3.56E-05 
protein binding 2855 77 43.47 + 5.81E-05 
cytokine activity 188 14 2.86 + 2.65E-04 
peptidase activity 747 30 11.37 + 2.98E-04 
structural molecule activity 1261 42 19.20 + 3.15E-04 
hydrolase activity 2332 64 35.51 + 4.13E-04 
cytokine receptor binding 64 8 0.97 + 1.26E-03 
receptor activity 1576 47 24.00 + 1.40E-03 
peptidase inhibitor activity 193 12 2.94 + 8.29E-03 
  
Table 3. Most significant cellular components related to POAG 
Cellular Component Homo sapiens (REF) # # Expected +/_ P value 
extracellular region 533 32 8.12 + 4.00E-09 
extracellular matrix 376 25 5.73 + 6.91E-08 
cell part 1592 40 24.24 + 6.94E-02 
Organelle 1051 28 16.00 + 1.67E-01 
Intracellular 1434 35 21.83 + 2.18E-01 
Cytoskeleton 786 22 11.97 + 2.57E-01 
intermediate filament cytoskeleton 73 5 1.11 + 2.84E-01 
 
Table 4.  Top 10 protein classes related to POAG 
 
 
PANTHER protein class Homo sapiens (REF) # # expected +/_ P-value 
extracellular matrix protein 466 28 7.10 + 2.24E-07 
signaling molecule 1048 40 15.96 + 2.20E-05 
extracellular matrix structural protein 93 11 1.42 + 5.01E-05 
defense/immunity protein 572 25 8.71 + 6.03E-04 
Cytokine 178 13 2.71 + 8.71E-04 
complement component 81 9 1.23 + 1.00E-03 
Surfactant 44 7 0.67 + 1.15E-03 
Hydrolase 1654 48 25.18 + 2.55E-03 
interleukin superfamily 36 6 0.55 + 4.09E-03 
Receptor 1597 46 24.32 + 4.73E-03 
 





Table 5. Most significant pathways derived from overrepresentation test 
Pathways Homo sapiens (REF) # # expected +/_ P-value 
apoptosis signaling pathway 113 19 1.72 + 5.54E-12 
huntington disease 142 18 2.16 + 2.66E-09 
interleukin signaling pathway 95 10 1.45 + 4.79E-04 
integrin signaling pathway 175 13 2.66 + 7.15E-04 
FAS signaling pathway 31 4 0.47 + 2.48E-01 
insulin/IGF pathway-mitogen activated 
protein kinase/MAP kinase cascade 
32 4 0.49 + 2.79E-01 
parkinson disease 88 6 1.34 + 4.46E-01 
Angiogenesis 152 8 2.31 + 4.56E-01 
 
Table 5 shows the results from over-representation 
test. It is shown in table5 that the top 5 significant 
pathways are apoptosis signaling pathway, 
Huntington disease, interleukin signaling pathway, 
integrin signaling pathway and Fas signaling 
pathway. In tables 1 to 5, second and third 
columns contain the number of genes in reference 
list and our list respectively.  Plus and minus signs 
in the fourth column show over- and under-
representations. P-value threshold is considered 
0.05. Pathways from functional classification by 
PANTHER are shown in figure 1.  
The pie chart shows the pathways related to our 
protein list. According to the chart, apoptosis 
signaling pathway, Huntington disease, integrin 
signaling pathway and gonadotropin releasing 
hormone receptor pathway are the most involved 
pathways in POAG patients.  Figure 2 shows the 










Figure 2. Pathway over representation diagram. Yellow bars show apoptosis signaling pathway, Huntington disease 
pathway, integrin signaling pathway and interleukin signaling pathway. Y axis is the log of fractional difference 
(observed vs expected) 
 
 











The network analysis was done using STRING 
server. The created network contained 312 
nodes and 1348 edges after removing the 
disconnected nodes. Figure 3, shows the 
network created by string server. The resulting 
network was then analyzed by CytoScape 
software. We used CytoCluster plugin to cluster 
our network into smaller subnetworks. Nine 
subnetworks were resulted. We used these 
clusters to find candidate biomarkers for POAG 
disease. Subnetworks were ranked according to 
their size. In each cluster, seed nodes were 
identified. Seed nodes are the highest weighted 
nodes in a graph. In the human protein-protein 
network, each node (protein) with 
corresponding gene expression value is 
regarded as “seed node.” For a seed node i, this 
node and its neighbors j  within the shortest 
distance k,  form a connected subnetwork 
with  n nodes [27]. 
 Here, we had seed nodes in clusters 1, 3, 4 and 
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    As mentioned, PANTHER classification 
system was used to classify the protein list of 
primary open angle glaucoma. Pathway analysis 
was done by overrepresentation test. As shown 
in table 5, the most significant pathway in our 
classification related to POAG is apoptosis 
signaling pathway. Apoptosis is critical for the 
normal development and function of 
multicellular organisms. Abnormalities in cell 
death control can contribute to a variety of 
diseases [28]. Evidence indicates that apoptosis 
may be the final common pathway for retinal 
ganglion cell (RGC) death in glaucoma. 
Apoptotic RGC death has been demonstrated in 
animal models of glaucoma [29, 30] . Markers 
of apoptosis have also been observed in the 
human glaucomatous retina [31-33]. 
The second most significant pathway in POAG 
was the Huntington disease. Anholt and carbone 
(2013) proposed that the accumulation of 
overexpressed or misfolded proteins such as 
myocilin associated with age-dependent onset 
of glaucoma, leads to ER stress when the 
unfolded protein response (UPR) pathway 
becomes unable of removing these proteins via 
the proteasome. The UPR is a conserved 
cellular pathway among all eukaryotes that 
protects cells against the accumulation and 
aggregation of misfolded proteins during 
protein synthesis. When the extent of 
aggregation of misfolded or damaged proteins 
exceeds the capacity of the UPR, it is no longer 
able to protect the ER from stress and this 
results in activation of apoptosis. This is the 
same process as in other neurodegenerative 
diseases such as Alzheimer, Parkinson and 
Huntington. Thus POAG can be placed in the 
same context as other adult late-onset 
neurodegenerative diseases [34]. 
The third most significant pathway in our 
classification was the interleukin signaling 
pathway. Several studies show the involvement 
of interleukins in the pathogenesis of glaucoma 
[35-37]. Johnson et al., showed that interleukin-
6-type cytokine signaling is implicated by gene 
expression responses in early optic nerve head 
injury in rat glaucoma [35].  
Fini et al., studied the role of interleukin-1-
regulated signaling pathways in normal and 
glaucomatous trabecular meshwork cells and 
showed that glaucomatous TM cells are unable 
to adapt to changes in extracellular levels of 
interleukin-1 [37]. 
The integrin signaling pathway is the other most 
important pathway in the classification. 
Integrins are crucially important because they 
are the main receptor proteins that cells use to 
both bind to and respond to the extracellular 
matrix. They are heterodimers and function as 
transmembrane linkers between the extracellular 
matrix and actin cytoskeleton. A cell can 
regulate the adhesive activity of its integrins 
from within. Integrins also function as signal 
transducers, activating various intracellular 
signaling pathways when activated by matrix 
binding. Integrins and conventional signaling 
receptors often cooperate to promote cell 
growth, cell survival, and cell proliferation [38]. 
Research efforts have been put in the last 
decade to elucidate cells response and ECM 
remodeling processes in the trabecular 
meshwork and the optic nerve head in glaucoma 
and integrins have been identified as very 
important participants in this process. In vitro 
and in vivo data strongly indicate that integrin-
mediated signaling events can modulate the 
organization of actin cytoskeleton in TM cells 
and are associated with astrocytes migration and 
microglia activation in the optic nerve head of 
glaucoma patients. As a result, increase in 
resistance in the TM outflow pathways and 
ECM remodeling of the optic nerve head occur. 
While increase in outflow resistance causes an 
increase in IOP, and the remodeling of the optic 
nerve head accompanies the optic nerve axons 
damage. Increase in IOP further adds 
mechanical stress and strain to optic nerve 
axons and accelerates axon damages. Integrins 
appear to be ideal candidates for translating 
physical stress and strain into cellular responses 
known to occur in glaucomatous optic 
neuropathy [39]. 
Another significant signaling pathway related to 
POAG was the Fas signaling pathway. The Fas 
receptor (CD95) mediates apoptotic signaling 
by Fas-ligand expressed on the surface of other 
cells. The Fas-FasL interaction plays an 
important role in the immune system and lack of 
this system leads to autoimmunity, indicating 
that Fas-mediated apoptosis removes self-
reactive lymphocytes. Fas signaling is also 
involved in immune surveillance to remove 
transformed cells and virus infected cells. 
Binding of Fas to FasL on another cell activates 
apoptotic signaling through a cytoplasmic 
domain termed the death domain that interacts 
with signaling adaptors including FAF, FADD 
 




and DAX to activate the caspase proteolytic 
cascade. Fas signaling pathway may involve in 
glaucoma mechanism. Agrawal et al. (1999), 
showed that human TM cells express Fas 
receptor and undergo apoptosis after activation 
of the receptor by monoclonal IgM. 
Razeghinejad and Kamali (2007), investigated 
aqueous humor levels of soluble Fas in 
glaucomatous patients and hypothesized that 
lower levels of S-Fas may provide proper 
microenvironment for increased apoptosis of 
trabecular meshwork cells in primary open 
angle glaucoma [40]. 
 The network analysis by CytoScape software 
developed 9 clusters of proteins which are 
highly condensed in the POAG network. In each 
cluster, seed nodes were determined presented 
in figure 4. The seed nodes which existed in our 
data set included SELE, CALM2 and DNAH6. 
These seed nodes can serve as candidate 
biomarkers for POAG disease. SELE is found in 
cytokine-stimulated endothelial cells and is 
thought to be responsible for the accumulation 
of blood leukocytes at sites of inflammation by 
mediating the adhesion of cells to the vascular 
lining. It is a part of the selectin family of cell 
adhesion molecules. Diseases associated with 
SELE include vasculitis, and leukostasis. GO 
annotations related to this gene include 
transmembrane signaling receptor activity and 
sialic acid binding. CALM2 (calmodulin 2 
(phosphorylase  kinase, delta))  mediates  the  
control of a large number of enzymes, ion    
channels, aquaporins and other proteins by 
Ca(2+). Among the enzymes to be simuldated 
by the calmodulin-Ca(2+) complex are a 
number of protein kinases and phosphatase. 
DNAH6 (dynein, axonemal, heavy chain 6) is 
the other seed protein. GO annotations related 
to this protein include microtubule motor 
activity and ATPase activity. Dyneins are 
microtubule-associated motor protein 
complexes composed of several heavy, light, 
and intermediate chains. Two major classes of 
dyneins, axonemal and cytoplasmic, have been 
identified. DNAH6 is an axonemal dynein 
heavy chain (DHC).  
 
CONCLUSION 
     In this study, using network and pathway  
analysis, GO biological process, protein class 
and cellular component, relationship between 
genes in POAG was identified that can be 
useful in identifying biomarker candidates and 
drug targets and to investigate possible disease 
mechanisms. Network analysis of POAG 
proteins, can help diagnose and predict 
treatments for the disease. From network 
analysis, 9 clusters were identified and 3 seed 
nodes were determined to be in our protein list 
which included SELE, CALM2 and DNAH6 
which can serve as candidate biomarkers for 
POAG disease but for detailed evaluation of 
these proteins, more investigations are needed. 
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